Kenek PIERS is a first-of-its-kind clinical decision aid that incorporates the most advanced predictive risk assessment algorithms ever developed which are being validated at unprecedented scale - over 70,000 subjects in four countries. Kenek PIERS represents a critical advancement in the field of clinical decision support and front-line healthcare.

Through innovative engineering, we have been able to tap into the computing power of mobile devices to produce medical-grade, low-cost vital signs monitoring systems amenable to widespread usage in low- and medium-resource countries. The impact is exponential: one low-cost sensor could be used by one local health worker to screen everyone in their community.

Guy A. Dumont, PHD, Advisor

Every year, more than two million kids die from infectious diseases before they reach the age of five. Pneumonia, malaria, diarrhea: all of these diseases go through a general deterioration that affects the entire body, including the lungs. That’s where we think this technology can be used to detect early on when these children are likely to develop complications. Our research and technology have put us on the precipice of tremendous change, reducing global health inequities.

Dr. Mark Ansermino, Pediatric Anesthesiologist, BC Children's Hospital

We developed our diagnostic kits to address some of the largest causes of mortality in low-income countries. The diagnostic platform provides a means of delivering training within the predictive app with multimedia content localized to the region’s languages and escalation protocols. This provides a community health worker with sophisticated tools to diagnose, treat locally, or escalate to a higher level of care.

Chris Petersen, PhD, Director of Technology Development, UBC Pediatric Anesthesia Research Team, BC Children's Hospital